Loading...

Ansell Limited

ANSLFPNK
Healthcare
Medical - Instruments & Supplies
$18.00
$0.00(0.00%)

Ansell Limited (ANSLF) Financial Performance & Income Statement Overview

Access detailed quarterly and annual financial reports for Ansell Limited (ANSLF), covering cash flow, earnings, and balance sheets.

Revenue Growth
-0.90%
0.90%
Operating Income Growth
-34.32%
34.32%
Net Income Growth
-48.42%
48.42%
Operating Cash Flow Growth
68.38%
68.38%
Operating Margin
10.10%
10.10%
Gross Margin
38.99%
38.99%
Net Profit Margin
6.07%
6.07%
ROE
5.72%
5.72%
ROIC
6.42%
6.42%

Ansell Limited (ANSLF) Income Statement & Financial Overview

Analyze Ansell Limited’s ANSLF earnings with segmented quarterly and yearly financial statement figures.

MetricQ4 2024Q2 2024Q4 2023Q3 2023
Revenue$834.40M$784.90M$808.21M$409.90M
Cost of Revenue$508.20M$486.30M$503.38M$254.35M
Gross Profit$326.20M$298.60M$304.83M$155.55M
Gross Profit Ratio$0.39$0.38$0.38$0.38
R&D Expenses$16.60M$0.00$8.95M$8.95M
SG&A Expenses$208.90M$220.40M$188.99M$96.80M
Operating Expenses$236.40M$259.10M$188.99M$97.55M
Total Costs & Expenses$744.60M$745.40M$692.37M$351.90M
Interest Income$0.00$1.88M$1.28M$4.35M
Interest Expense$0.00$12.63M$11.31M$0.00
Depreciation & Amortization$22.00M$25.10M$33.81M$10.50M
EBITDA$139.30M$103.30M$150.93M$69.25M
EBITDA Ratio$0.17$0.13$0.19$0.17
Operating Income$89.80M$39.50M$115.84M$58.75M
Operating Income Ratio$0.11$0.05$0.14$0.14
Other Income/Expenses (Net)-$10.30M-$10.30M-$10.06M-$5.10M
Income Before Tax$79.50M$29.20M$105.78M$53.65M
Income Before Tax Ratio$0.10$0.04$0.13$0.13
Income Tax Expense$22.00M$9.20M$21.89M$11.10M
Net Income$57.10M$19.40M$83.21M$42.20M
Net Income Ratio$0.07$0.02$0.10$0.10
EPS$0.43$0.15$0.66$0.33
Diluted EPS$0.43$0.15$0.65$0.33
Weighted Avg Shares Outstanding$132.93M$125.97M$126.30M$127.11M
Weighted Avg Shares Outstanding (Diluted)$132.90M$125.90M$127.10M$127.10M

Over the last four quarters, Ansell Limited's revenue moved from $409.90M in Q3 2023 to $834.40M in Q4 2024. Operating income in Q4 2024 was $89.80M, with a strong operating margin of 11%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Ansell Limited remained robust at $139.30M, reflecting operational efficiency. Net income rose to $57.10M, with an EPS of $0.43. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;